An expert panel on Tuesday recommended Covaxin – Bharat Biotech’s COVID-19 vaccine – for use on children between the ages of two and 18. That final approval – viewed as a formality – will be given by the Drug Controller General of India. When it does come, Covaxin will be only the second vaccine cleared for use on kids in India; in August Zydus Cadila’s three-dose DNA jab was allowed to be used on adults and children over 12.
#Covaxin #BharatBiotech #CovidVaccine #EmergencyUseAuthorization
Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
